Arbor Investment Advisors, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Arbor Investment Advisors, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$685,690
+5.9%
17,9500.0%0.12%
+5.3%
Q2 2023$647,457
-5.6%
17,9500.0%0.11%
-9.5%
Q1 2023$685,511
-32.9%
17,9500.0%0.13%
-39.7%
Q4 2022$1,021,355
+29.3%
17,9500.0%0.21%
+23.7%
Q2 2022$790,000
+10.3%
17,9500.0%0.17%
+23.4%
Q1 2022$716,000
-0.8%
17,9500.0%0.14%
+1.5%
Q4 2021$722,000
-1.1%
17,9500.0%0.14%
-8.2%
Q3 2021$730,000
-10.4%
17,9500.0%0.15%
-14.5%
Q2 2021$815,000
+9.0%
17,9500.0%0.17%
+2.4%
Q1 2021$748,000
-2.5%
17,9500.0%0.17%
-4.5%
Q4 2020$767,000
+62.5%
17,9500.0%0.18%
+43.1%
Q3 2020$472,000
-1.9%
17,9500.0%0.12%
-7.5%
Q2 2020$481,000
+48.9%
17,9500.0%0.13%
+24.3%
Q1 2020$323,000
+1.6%
17,9500.0%0.11%
+18.9%
Q4 2019$318,000
+14.4%
17,9500.0%0.09%
+7.1%
Q3 2019$278,000
-9.7%
17,9500.0%0.08%
-12.5%
Q2 2019$308,00017,9500.10%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders